Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imidazoles for vaginitis.

C R Lee1, C A McKenzie, A Nobles

  • 1Department of Pharmacy Practice, Campbell University School of Pharmacy, Buies Creek, N.C.

American Pharmacy
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anchoring device to prevent membrane detachment and preterm prelabor rupture of membranes after fetal intervention.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2024
Same author

Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic.

International journal of clinical pharmacy·2022
Same author

Miliary fibromas in tuberous sclerosis complex.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Thyroid nodules in xeroderma pigmentosum patients: a feature of premature aging.

Journal of endocrinological investigation·2020
Same author

Acute kidney injury as a risk factor of hyperactive delirium: A case control study.

Journal of critical care·2019
Same author

Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology.

The pharmacogenomics journal·2017
Same journal

Genetically engineered vaccines.

American pharmacy·1995
Same journal

GAO report on need for a third class: 'prove it'.

American pharmacy·1995
Same journal

Treatment of community-acquired urinary tract infections.

American pharmacy·1995
Same journal

Liability and the changing role of pharmacists.

American pharmacy·1995
Same journal

Dispensing errors and counseling in community practice.

American pharmacy·1995
Same journal

Avoiding liability problems. American Pharmaceutical Association.

American pharmacy·1995
See all related articles

Over-the-counter clotrimazole and miconazole are now effective treatments for vaginal candidiasis. These imidazole antifungals offer improved patient compliance due to shorter regimens and greater efficacy compared to older therapies.

Area of Science:

  • Mycology
  • Pharmacology
  • Women's Health

Background:

  • Vaginal candidiasis is a prevalent fungal infection affecting women.
  • Several therapeutic agents exist for treating this condition.
  • Clotrimazole and miconazole, introduced in 1975, are now available over-the-counter (OTC).

Purpose of the Study:

  • To review the efficacy and availability of current treatments for vaginal candidiasis.
  • To highlight the shift in therapeutic preference towards imidazole agents.
  • To inform about the cost-effectiveness of OTC antifungal regimens.

Main Methods:

  • Literature review of antifungal agents for vaginal candidiasis.
  • Comparison of imidazole agents (clotrimazole, miconazole) with nystatin.

Related Experiment Videos

  • Analysis of treatment regimen duration and patient compliance factors.

    • Main Results:

    • Imidazole agents demonstrate greater antifungal activity than nystatin.
    • Shorter treatment regimens enhance patient compliance.
    • OTC imidazole regimens range from $12.00 to $24.00.

    Conclusions:

    • Clotrimazole and miconazole have become primary therapies for vaginal candidiasis.
    • The availability of these agents over-the-counter improves accessibility.
    • Imidazole antifungals offer advantages in efficacy and patient compliance.